Our company is always looking for new, innovative thinkers. Join our growing team and help us build a new kind of biopharma. Explore our current openings: endpointhealth.com/careers/

We are proud to announce that we closed $52 million in equity and debt financing in our Series A. Read more about how these funds will accelerate our mission to deliver new precision therapies to patients in need.

We care about each and every patient at ENDPOINT HEALTH, which is why we are working to develop therapies designed for patients’ unique clinical needs. Learn more here - endpointhealth.com/about-us/

Exciting to see our Series A financing highlighted by Nasdaq in New York! We’re extremely proud of this milestone and grateful to all those supporting us on the mission to improve outcomes for patients.

As we head into the weekend, I’m excited to spend some quality time with my family. Wishing those of you celebrating #FathersDay, including my fellow “working dads” at ENDPOINT HEALTH, a happy and relaxing holiday.

I had the privilege to speak with Rafael Rosengarten and the "Talking Precision Medicine" podcast about Endpoint Health's work in precision immunology, insights on founding a company and how to build the right team. Check it out!

By rewriting the molecule-first drug development model, ENDPOINT HEALTH aims to deliver #precisionfirst therapeutics that have the potential to improve outcomes for patients with immune-mediated diseases. Learn more: endpointhealth.com/about-us/

An article published today in Forbes offers leadership advice from our very own @DiegoARey, member of the Forbes Technology Council. Diego tells leaders they shouldn’t be hesitant to launch a company, even if they don't have a fully developed idea. Forbes Councils bit.ly/3RGJROX

As a CEO, I am proud of the incredible team we’ve been building here at ENDPOINT HEALTH. This group of seasoned industry professionals is succeeding both at and away from their desks – visit our site to find out what makes them unique: bit.ly/3b1krLA

I was honored to speak at SynBioBeta's Built with Biology conference about the precision medicine ecosystem. At ENDPOINT HEALTH we differentiate ourselves by in-licensing and developing therapies, always focusing on the patient. Watch more here: bit.ly/3PJgESp

At ENDPOINT HEALTH, our vision is a world in which all patients get the best treatment possible for their unique biology and disease. Check out our precision-first approach to successfully deliver personalized treatment for patients: endpointhealth.com/our-approach/

I was honored to be interviewed for the Labiotech.eu Beyond Biotech podcast about ENDPOINT HEALTH, our robust pipeline, and our bright future. Thank you for a great dialogue!! Check out the interview here: podcast.labiotech.eu/1995493/111648…

Today ENDPOINT HEALTH joined the exclusive Y Combinator Top Companies list. I am so proud of our company and the employees who have worked tirelessly to qualify us for this incredible industry recognition. Read more here: bit.ly/3AGveF3

We are pioneering a new precision immunology ecosystem at ENDPOINT HEALTH that mobilizes the clinical and data partners necessary to advance precision-first therapeutics for both acute and chronic immune-mediated diseases. Click to Learn more: endpointhealth.com/partnering/

We’re pleased to announce the appointment of Ransi Somaratne as our new Chief Medical Officer (#CMO)! Learn more about the expertise Dr. Somaratne brings to our leadership team here: endpointhealth.com/news/endpoint-… #BioPharma #Leadership #LifeScience #PrecisionMedicine #AI

I love learning about how our talented team members grow when they’re both in and outside of the office. So excited that Dr. Ransi Somaratne has joined our team!

At ENDPOINT HEALTH, we use a Patient-First approach with a mission to develop precision therapies that have the potential to improve outcomes for patients with immune-mediated diseases. Learn more: endpointhealth.com/about-us/

Proud of ENDPOINT HEALTH’s newest precision immunology program! A first-in-class therapy…an innovative AI platform for patient selection. Our aim: transform immune-mediated inflammatory disease treatment with novel precision medicine strategies. Read more endpointhealth.com/news/endpoint-…

We are building a new kind of biopharma company by putting the patient first. Our model shines a light on which therapy will work best for each patient. Learn more: endpointhealth.com/about-us/ #BioPharma #AI #LifeScience

#NewHire: Join us in welcoming Julie Friedman as our new VP of Therapeutic Operations & Program Management! Julie brings 30+ years of experience at both small and large Pharma/Biotech companies and we are so happy to have her on our team! #BioPharma #Leadership #AI #LifeScience